The anterior approach to total hip arthroplasty may provide a significant increase in hip function and reductions in pain and narcotics use through the first 90 days post-op vs. a posterior approach, with no statistical difference in complication rates.
DePuy Synthes performed a meta-analysis of 13 prospective, comparative studies (7 randomized) published between 2006 and 2017, assessing >1,000 patients. The meta-analysis sought to address components of the CJR model (complication rate, patient satisfaction, pain management over 90 days).
The study, “Does Surgical Approach Affect Outcomes in Total Hip Arthroplasty Through 90 Days of Follow-Up? A Systematic Review with Meta-Analysis,” is available online in the Journal of Arthroplasty.
DePuy cited leadership in the anterior approach in U.S. hips among growth drivers supporting a year over year revenue increase in its hip sales for 4Q17.
The anterior approach to total hip arthroplasty may provide a significant increase in hip function and reductions in pain and narcotics use through the first 90 days post-op vs. a posterior approach, with no statistical difference in complication rates.
DePuy Synthes performed a meta-analysis of 13 prospective, comparative studies (7...
The anterior approach to total hip arthroplasty may provide a significant increase in hip function and reductions in pain and narcotics use through the first 90 days post-op vs. a posterior approach, with no statistical difference in complication rates.
DePuy Synthes performed a meta-analysis of 13 prospective, comparative studies (7 randomized) published between 2006 and 2017, assessing >1,000 patients. The meta-analysis sought to address components of the CJR model (complication rate, patient satisfaction, pain management over 90 days).
The study, “Does Surgical Approach Affect Outcomes in Total Hip Arthroplasty Through 90 Days of Follow-Up? A Systematic Review with Meta-Analysis,” is available online in the Journal of Arthroplasty.
DePuy cited leadership in the anterior approach in U.S. hips among growth drivers supporting a year over year revenue increase in its hip sales for 4Q17.
Copy to clipboard 
